Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series

Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series

This case series study is the first report of Japanese adolescents who experienced dupilumab facial redness after starting dupilumab treatment for refractory atopic dermatitis. In every case, dupilumab facial redness subsided without discontinuation of dupilumab within 3 months after onset.

Bibliographic Details
Main Authors: Shuhei Hara, MD, Takaaki Itonaga, MD, Makoto Nishino, MD, Noriyuki Yanagida, MD, PhD, Sakura Sato, MD, Motohiro Ebisawa, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Atopic dermatitis
dupilumab
Japanese adolescent
erythema
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829323000218

Internet

http://www.sciencedirect.com/science/article/pii/S2772829323000218

Similar Items